InnovAge Holding Corp. (INNV) Financial Ratios
7 years of historical data (2019–2025) · Healthcare · Medical - Care Facilities
EV/EBITDA
↑
N/A
—
5yr avg: 41.83
30Y Low31.8·High51.9
P/FCF
45.76
↑+144% vs avg
5yr avg: 18.78
30Y Low18.8·High18.8
P/B Ratio
↓
4.62
↑+34% vs avg
5yr avg: 3.46
30Y Low1.7·High8.1
ROE
↑
-10.8%
-6% vs avg
5yr avg: -10.2%
30Y Low-19%·High28%
Debt/EBITDA
↑
N/A
—
5yr avg: 4.93
30Y Low0.9·High8.9
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
INNV Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
InnovAge Holding Corp. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis. On a free-cash-flow basis, the stock trades at 45.8x P/FCF, 144% above the 5-year average of 18.8x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Market Cap | $1.2B | $500M | $674M | $1.0B | $594M | $2.9B | — | — |
| Enterprise Value | $1.3B | $537M | $730M | $1.1B | $494M | $2.8B | — | — |
| P/E Ratio → | -40.77 | — | — | — | — | — | — | — |
| P/S Ratio | 1.43 | 0.59 | 0.88 | 1.48 | 0.85 | 4.53 | — | — |
| P/B Ratio | 4.62 | 1.90 | 2.25 | 3.39 | 1.68 | 8.07 | — | — |
| P/FCF | 45.76 | 18.78 | — | — | — | — | — | — |
| P/OCF | 37.04 | 15.20 | — | — | 21.74 | — | — | — |
P/E links to full P/E history page with 30-year chart
INNV EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 0.63 | 0.96 | 1.56 | 0.71 | 4.34 | — | — |
| EV / EBITDA | — | — | — | — | 51.90 | 31.76 | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — |
| EV / FCF | — | 20.17 | — | — | — | — | — | — |
INNV Profitability
Margins and return-on-capital ratios measuring operating efficiency
InnovAge Holding Corp. earns an operating margin of -3.5%. Operating margins have expanded from -7.2% to -3.5% over the past 3 years, signaling improving operational efficiency. A negative ROE of -10.8% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 68.5% | 68.5% | 17.3% | 14.7% | 19.4% | 25.4% | 24.9% | 23.8% |
| Operating Margin | -3.5% | -3.5% | -3.0% | -7.2% | -0.6% | 11.7% | 9.0% | 8.5% |
| Net Profit Margin | -3.6% | -3.6% | -2.8% | -5.9% | -0.9% | -6.9% | 4.6% | 4.2% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| ROE | -10.8% | -10.8% | -7.1% | -12.4% | -1.8% | -18.9% | 27.8% | 24.0% |
| ROA | -5.3% | -5.3% | -3.8% | -7.3% | -1.2% | -9.3% | 6.8% | 5.4% |
| ROIC | -6.8% | -6.8% | -4.9% | -12.1% | -1.3% | 25.1% | 17.9% | 13.8% |
| ROCE | -7.1% | -7.1% | -5.5% | -11.4% | -1.0% | 18.9% | 16.6% | 14.2% |
INNV Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Net debt stands at $37M ($101M total debt minus $64M cash).
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.38 | 0.38 | 0.38 | 0.38 | 0.24 | 0.23 | 2.02 | 2.39 |
| Debt / EBITDA | — | — | — | — | 8.91 | 0.95 | 3.50 | 4.00 |
| Net Debt / Equity | — | 0.14 | 0.19 | 0.19 | -0.28 | -0.34 | 0.96 | 1.64 |
| Net Debt / EBITDA | — | — | — | — | -10.47 | -1.39 | 1.66 | 2.74 |
| Debt / FCF | — | 1.39 | — | — | — | — | 3.23 | 11.70 |
| Interest Coverage | -3.50 | -3.50 | -4.42 | -32.37 | -1.87 | -1.08 | 3.44 | 3.85 |
INNV Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.07x means InnovAge Holding Corp. can comfortably meet its short-term obligations, though there is limited excess liquidity. The current ratio has declined from 1.25x to 1.07x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.07 | 1.07 | 1.25 | 1.25 | 2.29 | 3.19 | 2.18 | 1.43 |
| Quick Ratio | 1.07 | 1.07 | 1.25 | 1.25 | 2.29 | 3.19 | 2.18 | 1.43 |
| Cash Ratio | 0.64 | 0.64 | 0.74 | 0.74 | 1.75 | 2.59 | 1.49 | 0.73 |
| Asset Turnover | — | 1.53 | 1.32 | 1.26 | 1.24 | 1.18 | 1.38 | 1.28 |
| Inventory Turnover | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | 16.97 | 24.58 | 27.28 | 22.29 | 21.74 | 30.92 | 43.12 |
INNV Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
InnovAge Holding Corp. returns 0.6% to shareholders annually primarily through share buybacks.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | 0.3% | — | — |
| Payout Ratio | — | — | — | — | — | — | — | 339.7% |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — |
| FCF Yield | 2.2% | 5.3% | — | — | — | — | — | — |
| Buyback Yield | 0.6% | 1.5% | 0.0% | 0.0% | 0.0% | 2.7% | — | — |
| Total Shareholder Yield | 0.6% | 1.5% | 0.0% | 0.0% | 0.0% | 3.0% | — | — |
| Shares Outstanding | — | $135M | $136M | $136M | $136M | $136M | $133M | $133M |
Peer Comparison
Compare INNV with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 INNVYou | $1B | -40.8 | — | 45.8 | 68.5% | -3.5% | -10.8% | -6.8% | — |
 ALHC | $4B | -5908.1 | 93.4 | 39.5 | 12.4% | 0.4% | -0.5% | — | 7.5 |
 OSCR | $7B | -16.8 | — | 7.0 | 14.4% | -3.4% | -44.4% | — | — |
 ENSG | $9B | 26.3 | 23.5 | 24.2 | 13.7% | 8.6% | 16.9% | 7.0% | 7.7 |
 CCRN | $426M | -4.5 | 24.0 | 10.6 | 18.7% | -0.3% | -25.6% | -0.9% | 0.2 |
 UNH | $364B | 30.3 | 17.9 | 22.6 | 18.5% | 4.2% | 11.8% | 9.2% | 3.4 |
 HUM | $43B | 36.7 | 22.9 | 115.5 | 14.5% | 1.1% | 7.0% | 4.1% | 5.7 |
 CVS | $125B | 70.7 | 14.0 | 16.1 | 13.8% | 2.6% | 2.3% | 5.0% | 6.2 |
 CNC | $30B | -4.5 | — | 7.0 | 12.2% | -3.9% | -28.7% | -21.6% | — |
 MOH | $10B | 21.9 | 10.1 | — | 9.0% | 1.7% | 11.0% | 17.4% | 4.0 |
 WELL | $145B | 148.7 | 64.6 | 50.8 | 39.2% | 3.3% | 2.5% | 0.5% | 8.6 |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 7 years · Updated daily
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
INNV — Frequently Asked Questions
Quick answers to the most common questions about buying INNV stock.
What is InnovAge Holding Corp.'s P/E ratio?
InnovAge Holding Corp.'s current P/E ratio is -40.8x. This places it at the 50th percentile of its historical range.
What is InnovAge Holding Corp.'s ROE?
InnovAge Holding Corp.'s return on equity (ROE) is -10.8%. The historical average is 0.1%.
Is INNV stock overvalued?
Based on historical data, InnovAge Holding Corp. is trading at a P/E of -40.8x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are InnovAge Holding Corp.'s profit margins?
InnovAge Holding Corp. has 68.5% gross margin and -3.5% operating margin.